- Pavletic has been promoted to help lead Jeito’s growth plans
- Prior to joining Jeito, Pavletic was CEO of reproductive health pharma company PregLem
- Jeito is an independent private equity fund dedicated to biopharma
Jeito Capital has promoted Ksenija Pavletic to partner investor.
Pavletic has been promoted to help lead Jeito’s growth plans, according to a press statement.
Pavletic is part of Jeito’s founding team and has served as the firm’s chief commercial officer. Prior to joining Jeito, she was CEO of Swiss-based, reproductive health pharma company PregLem.
Jeito Capital is a Paris-based firm with €534 million under management. The fund is dedicated to biopharma.